Gupta R S
Cancer Res. 1983 Feb;43(2):505-12.
The cross-resistances of several mutants of Chinese hamster ovary cells which have been obtained after one and two selection steps in the presence of the microtubule inhibitor podophyllotoxin (PodRI and PodRII mutants, respectively) towards various other inhibitors of microtubule assembly (e.g., colchicine, Colcemid, vinblastine, griseofulvin, maytansine, steganacin, nocodazole, and taxol) have been examined. Based upon their specific patterns of cross-resistance/sensitivity to various microtubule inhibitors, both the PodRI and PodRII classes of mutants appear to be of more than one kind. Studies on the binding of [3H]podophyllotoxin to cytoplasmic extracts indicate that one of the PodRII mutants which has been shown previously to be affected in a Mr 66,000 to 68,000 microtubule-associated protein shows reduced binding of the drug in comparison to the parental PodS and PodRI cells. The different PodRI and PodRII mutants exhibited proportionally increased cross-resistances to various podophyllotoxin analogues (e.g., deoxypodophyllotoxin, epipodophyllotoxin, beta-peltatin, 4'-demethylpodophyllotoxin, alpha-peltatin, podophyllotoxin-beta-D-glucoside, beta-peltatin-beta-D-glucoside, picropodophyllotoxin, and podophyllic acid) which possess microtubule-inhibitory activity. However, with the exception of one PodRI class of mutant, none of the mutants exhibited any cross-resistance to 4'-demethylepipodophyllotoxin thenylidine-beta-D-glucoside and 4'-demethylepipodophyllotoxin ethylidine-beta-D-glucoside, the 2 podophyllotoxin analogues which lack microtubule-inhibitory activity. The cross-resistance studies with these mutants, which, based upon the biochemical studies and their highly specific patterns of cross-resistance, are presumably affected in microtubules, provide some very novel insights into the mechanisms of action of various microtubule inhibitors. The results presented in this paper also show that the cross-resistance studies with the set of podophyllotoxin-resistant mutants provide a sensitive and highly specific screening procedure for identifying compounds which possess podophyllotoxin-like activity and for investigating the structure-activity relationship among them. The results of structure-activity relationship studies for the various podophyllotoxin analogues examined are discussed.
对中国仓鼠卵巢细胞的几种突变体的交叉抗性进行了研究,这些突变体是在微管抑制剂鬼臼毒素存在的情况下经过一轮和两轮筛选步骤获得的(分别为PodRI和PodRII突变体),研究对象是各种其他微管组装抑制剂(例如秋水仙碱、秋水仙酰胺、长春碱、灰黄霉素、美登素、隐丹参酮、诺考达唑和紫杉醇)。根据它们对各种微管抑制剂的交叉抗性/敏感性的特定模式,PodRI和PodRII两类突变体似乎都不止一种。对[3H]鬼臼毒素与细胞质提取物结合的研究表明,先前已证明一种PodRII突变体在一种分子量为66,000至68,000的微管相关蛋白中受到影响,与亲本PodS和PodRI细胞相比,该突变体对药物的结合减少。不同的PodRI和PodRII突变体对各种具有微管抑制活性的鬼臼毒素类似物(例如脱氧鬼臼毒素、表鬼臼毒素、β-盾叶鬼臼素、4'-去甲基鬼臼毒素、α-盾叶鬼臼素、鬼臼毒素-β-D-葡萄糖苷、β-盾叶鬼臼素-β-D-葡萄糖苷、足叶草毒素、鬼臼酸)表现出成比例增加的交叉抗性。然而,除了一类PodRI突变体之外,没有一个突变体对4'-去甲基表鬼臼毒素噻吩甲基-β-D-葡萄糖苷和4'-去甲基表鬼臼毒素乙叉基-β-D-葡萄糖苷这两种缺乏微管抑制活性的鬼臼毒素类似物表现出任何交叉抗性。对这些突变体的交叉抗性研究——基于生化研究及其高度特异性的交叉抗性模式,推测这些突变体在微管中受到影响——为各种微管抑制剂的作用机制提供了一些非常新颖的见解。本文给出的结果还表明对一组鬼臼毒素抗性突变体进行的交叉抗性研究为鉴定具有鬼臼毒素样活性的化合物以及研究它们之间的构效关系提供了一种灵敏且高度特异的筛选方法。讨论了对所检测的各种鬼臼毒素类似物的构效关系研究结果。